cyclohexyl(tetrahydro-2H-pyran-4-yl)methanone | 854696-45-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 英文名称: cyclohexyl(tetrahydro-2H-pyran-4-yl)methanone
• 英文别名: cyclohexyl-tetrahydropyran-4-yl ketone；Cyclohexyl-tetrahydropyran-4-yl-keton；Cyclohexyl(oxan-4-yl)methanone
• CAS: 854696-45-0
• 化学式: C₁₂H₂₀O₂
• 分子量: 196.29
• InChiKey: WHVAWYMJPZAYQQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  cyclohexyl(tetrahydro-2H-pyran-4-yl)methanone 在 正丁基锂 、 氯化亚砜 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 62.0h， 生成 2-(2-cyclohexyl-2-(tetrahydro-2H-pyran-4-yl)ethyl)piperidine
  参考文献：
  名称：

  Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy

  摘要：

  We designed and synthesized perhexiline analogues that have the same therapeutic profile as the parent cardiovascular drug but lacking its metabolic liability associated with CYP2D6 metabolism. Cycloalkyl perhexiline analogues 6a-j were found to be unsuitable for further development, as they retained a pharmacokinetic profile very similar to that shown by the parent compound. Multistep synthesis of perhexiline analogues incorporating fluorine atoms onto the cyclohexyl ring(s) provided a range of different fluoroperhexiline analogues. Of these, analogues 50 (4,4-gem-difluoro) and 62 (4,4,4',4'-tetrafluoro) were highly stable and showed greatly reduced susceptibility to CYP2D6-mediated metabolism. In vitro efficacy studies demonstrated that a number of derivatives retained acceptable potency against CPT-1. Having the best balance of properties, 50 was selected for further evaluation. Like perhexiline, it was shown to be selectively concentrated in the myocardium and, using the Langendorff model, to be effective in improving both cardiac contractility and relaxation when challenged with high fat buffer.

  DOI：

  10.1021/acs.jmedchem.6b01592
• 作为产物：
  描述：

  4-溴四氢吡喃 在 碘 、 戴斯-马丁氧化剂 、 magnesium 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 8.5h， 生成 cyclohexyl(tetrahydro-2H-pyran-4-yl)methanone
  参考文献：
  名称：

  Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy

  摘要：

  We designed and synthesized perhexiline analogues that have the same therapeutic profile as the parent cardiovascular drug but lacking its metabolic liability associated with CYP2D6 metabolism. Cycloalkyl perhexiline analogues 6a-j were found to be unsuitable for further development, as they retained a pharmacokinetic profile very similar to that shown by the parent compound. Multistep synthesis of perhexiline analogues incorporating fluorine atoms onto the cyclohexyl ring(s) provided a range of different fluoroperhexiline analogues. Of these, analogues 50 (4,4-gem-difluoro) and 62 (4,4,4',4'-tetrafluoro) were highly stable and showed greatly reduced susceptibility to CYP2D6-mediated metabolism. In vitro efficacy studies demonstrated that a number of derivatives retained acceptable potency against CPT-1. Having the best balance of properties, 50 was selected for further evaluation. Like perhexiline, it was shown to be selectively concentrated in the myocardium and, using the Langendorff model, to be effective in improving both cardiac contractility and relaxation when challenged with high fat buffer.

  DOI：

  10.1021/acs.jmedchem.6b01592

文献信息

• Nickel-Catalyzed Electro-Reductive Cross-Coupling of Aliphatic <i>N</i>-Acyl Imides with Alkyl Halides as a Strategy for Dialkyl Ketone Synthesis: Scope and Mechanistic Investigations
  作者：Taline Kerackian、Didier Bouyssi、Guillaume Pilet、Maurice Médebielle、Nuno Monteiro、Julien C. Vantourout、Abderrahmane Amgoune

  DOI：10.1021/acscatal.2c03268

  日期：2022.10.7

  study of a cross-electrophile coupling of alkyl N-acyl imides with alkyl halides relying on the combination of nickel catalysis and electrochemistry are described. This methodology takes advantages of the stability and simple access of N-acyl imides as coupling partners for the selective synthesis of dissymmetric dialkyl ketones. Noteworthy, the developed electrochemical protocol affords selective access

  描述了依靠镍催化和电化学相结合的烷基N-酰基酰亚胺与烷基卤化物的交叉亲电偶联的发展和深入研究。该方法利用N-酰基酰亚胺作为偶联伙伴的稳定性和简单获取的优势，用于选择性合成不对称二烷基酮。值得注意的是，当使用具有不同链长的伯烷基溴化物时，开发的电化学方案提供了对线性烷基酮的选择性访问。包括循环伏安法、化学计量反应和催化中间体分离在内的机理研究为单价 (bpy) 镍介导的卤代烷和烷基N活化提供了一系列基本见解-酰基酰亚胺。烷基溴通过单电子氧化与电生成的 (bpy)Ni(I) 物质反应生成烷基自由基。N-酰基酰亚胺显示出在 (bpy)Ni(0) 和 (bpy)Ni(I) 物种上发生自发的 C-N 键氧化加成，从而生成 Ni(II) 酰基中间体。稳定的镍 (II) 酰基配合物也已被分离和充分表征，并证明了其催化能力。最后，显示电生成的 (bpy)Ni(I)-酰基物质与烷基溴和烷基N-酰基酰亚胺反应
• Hydantoins Containing a Tetrahydropyranyl Substituent¹
  作者：Henry R. Henze、Robert L. McKee

  DOI：10.1021/ja01259a057

  日期：1942.7